Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC – Get Free Report) shares traded up 0.4% on Thursday . The company traded as high as $30.85 and last traded at $30.72. 2,700 shares were traded during mid-day trading, a decline of 10% from the average session volume of 2,984 shares. The stock had previously closed at $30.60.
Virtus LifeSci Biotech Clinical Trials ETF Price Performance
The company’s 50-day moving average is $28.58 and its two-hundred day moving average is $27.48.
About Virtus LifeSci Biotech Clinical Trials ETF
The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.
Featured Stories
- Five stocks we like better than Virtus LifeSci Biotech Clinical Trials ETF
- What is the Hang Seng index?
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- What is a Dividend King?
- Breakout Alert: Qualcomm Just Hit The Rally Button
- What is the Euro STOXX 50 Index?
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Virtus LifeSci Biotech Clinical Trials ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and related companies with MarketBeat.com's FREE daily email newsletter.
